Rociletinib (CO-1686)

rociletinib · Clovis Oncology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rociletinib (CO-1686), covering 2016-05-17 to 2016-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) [Phase 2]